What does CUSIP 69329YAC8 represent in this 13F holders report?

CUSIP 69329YAC8 is the security identifier for 69329YAC8 - PDL BIOPHARMA INC - NOTE 3.750% 5/0 used to aggregate holder disclosures.

How many institutions held 69329YAC8 - PDL BIOPHARMA INC - NOTE 3.750% 5/0 in Q2 2015?

No institutional holders were reported for 69329YAC8 - PDL BIOPHARMA INC - NOTE 3.750% 5/0 in Q2 2015; review adjacent reporting periods for trend context.

PDL BIOPHARMA INC - NOTE 3.750% 5/0

CUSIP: 69329YAC8

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Debt / NOTE 3.750% 5/0
Total 13F principal: $0
Principal change: -$17,723,000
Total reported market value: $0
Number of holders: 0
Value change: -$21,786,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 69329YAC8?
CUSIP 69329YAC8 identifies 69329YAC8 - PDL BIOPHARMA INC - NOTE 3.750% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q1 2015

Recent filing periods for CUSIP 69329YAC8:

Q2 2015 Q1 2015 Q4 2014 Q3 2014 Q2 2014 Q1 2014 Q4 2013 Q3 2013

PDL BIOPHARMA INC - NOTE 3.750% 5/0

Q2 2015 13F Holders as of 30 Jun 2015

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of PDL BIOPHARMA INC - NOTE 3.750% 5/0 as of Q2 2015.